In-hospital predictors of major complications following intracoronary stenting with ticlopidine-aspirin in patients with unstable angina A rational basis for the selected use of glycoprotein IIb/IIIa inhibitors
Angioi, M.; Bauters, C.; Gangloff, C.; Van Belle, E.; Vancon, A.C.; Lablanche, J.M.; Danchin, N.; Bertrand, M.E.
European Heart Journal 20(ABSTR Suppl ): 529
1999
ISSN/ISBN: 0195-668X
Accession: 035111660
PDF emailed within 1 workday: $29.90
Related References
Angioi, M.; Danchin, N.; Gangloff, C.; Grentzinger, A.; Jacquemin, L.; Berder, V.; Houplon, P.; Julliere, Y.; Cherrier, F. 1998: Ticlopidine-aspirin as antithrombotic regimen for intracoronary stenting for unstable angina Is there a need for further antiplatelet therapy? Journal of the American College of Cardiology 31(2 Suppl A): 100AAngioi, M.; Gangloff, C.; Grentzinger, A.; Jacquemin, L.; Preiss, J.P.; Berder, V.; Houplon, P.; Chopat, P.; Juilliere, Y.; Cherrier, F.; Danchin, N. 1998: Does the use of intracoronary stenting followed by ticlopidine-aspirin for unstable angina preclude the use of additional antithrombotic therapy? European Heart Journal 19(ABST Suppl ): 238
Angioi, M.; Danchin, N.; Alla, F.; Gangloff, C.; Sunthorn, H.; Rodriguez, R.M.; Preiss, J.P.; Grentzinger, A.; Houplon, P.; Juillière, Y.; Cherrier, F. 2000: Long-term outcome in patients treated by intracoronary stenting with ticlopidine and aspirin, and deleterious prognostic role of unstable angina pectoris American Journal of Cardiology 85(9): 1065-1070
Boughalem, K.; Pagny, J.Y.; Demicheli, T.; Danchin, N. 2001: Les inhibiteurs de la glycoprotéine IIb IIIa dans l'angor instable - Platelet glycoprotein IIb/IIIa inhibitors in unstable angina Annales de Cardiologie et d'Angeiologie (Paris) 50(7-8): 377-384
Harding, S.A.; Boon, N.A.; Flapan, A.D. 2002: Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three? Heart (London 1996) 88(1): 11-14
Harding, S.A.; Boon, N.A.; Flapan, A.D. 2002: Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three? Heart 88(1): 11-14
Theroux, P. 1997: Glycoprotein IIb/IIIa inhibitors in unstable angina Current Opinion in Cardiology 12(5): 447-452
Boughalem, K.; Pagny, J.Y.; Demichéli, T.; Danchin, N. 2001: Glycoprotein IIb/IIIa inhibitors in unstable angina Annales de Cardiologie et d'Angeiologie 50(7-8): 377-384
Ageno, W.; Turpie, A.G. 1999: The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina Giornale Italiano di Cardiologia 29(11): 1357-1365
Alexander, K.P.; Chen, A.Y.; Newby, L.Kristin.; Schwartz, J.B.; Redberg, R.F.; Hochman, J.S.; Roe, M.T.; Gibler, W.Brian.; Ohman, E.Magnus.; Peterson, E.D. 2006: Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative Circulation 114(13): 1380-1387
Scrutinio, D.; Lagioia, R.; Rizzon, P. 1991: Ticlopidine treatment for patients with unstable angina at rest. a further analysis of the study of ticlopidine in unstable angina. Studio della Ticlopidina nell'Angina Instabile Group European Heart Journal 12 Suppl G: 27-29
Crosbie, D.J. 2005: Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction Emergency Medicine Australasia: Ema 17(5-6): 500-510
Scapa, E.; Battler, A.; Hasdai, D. 2000: Role of glycoprotein IIb/IIIa inhibitors in unstable angina: current perspectives Cardiology in Review 8(6): 348-353
Cannon, C.P. 1999: Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction Coronary Artery Disease 10(8): 561-566
Galassi, A.R.; Ragusa, A.; Tomaselli, A.; Giannotta, D.; Grasso, C.; Pulvirenti, A.; Scriffignano, V.; Tamburino, C.; Giuffrida, G. 2001: Usefulness of glycoprotein IIb/IIIa inhibitors in unstable angina due to small vessel disease Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2(12): 927-931
Kirichenko, A.A.; Mantserova, O.A.; Lebedeva, A.I.; D'iachkova, N.V.; Voloshina, N.M.; Mazurov, V.I.; Nifontov, V.M.; Tyrenko, V.V.; Kolina, I.G.; Cherkashina, A.L.; Shkodina, N.V.; Mazalov, K.V.; Spiropulos, N.A.; Eremenko, I.A.; Kuzin, A.I. 2007: Unstable angina: efficacy and tolerability of therapy with aspirin and aspirin combined with ticlopidine Kardiologiia 47(5): 24-27
Antman, E.M. 2003: Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines American Heart Journal 146(4 Suppl): S18-S22
Latulippe, M.; Lang, E.S. 2010: Update: Use of platelet glycoprotein IIb/IIIa inhibitors in patients with unstable angina and non-ST-segment elevation myocardial infarction Annals of Emergency Medicine 56(5): E1-E2
Kassaian, S.Ebrahim.; Fathi, Y.; Lotfi-Tokaldany, M.; Salarifar, M.; Alidoosti, M.; Haji-Zeinali, A-Mohammad.; Aghajani, H.; Amirzadegan, A.; Nozari, Y.; Mortazavi, S.Hamideh.; Jalali, A.; Saroukhani, S. 2016: Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors Critical Pathways in Cardiology 15(3): 89-94
Almeda, F.Q.; Calvin, J.E.; Go, V.U.; Parrillo, J.E.; Klein, L.W. 2000: Contemporary trends in the incidence and etiology of abrupt vessel closure complicating percutaneous coronary interventions The impact of intracoronary stenting and glycoprotein IIb/IIIa inhibitors Journal of Investigative Medicine 48(5): 238A